These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35245356)

  • 1. Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225-2230.
    Quinn LM; Thayakaran R; Thomas N; Nirantharakumar K; Narendran P
    Diabetes Care; 2022 Mar; 45(3):e70-e71. PubMed ID: 35245356
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777-783.
    Fleischer J; Cichosz SL; Hansen TK
    Diabetes Care; 2017 Nov; 40(11):e164. PubMed ID: 29061593
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777-783.
    Lachin JM; Bebu I; Bergenstal RM; Pop-Busui R; Service FJ; Zinman B; Nathan DM;
    Diabetes Care; 2017 Nov; 40(11):e165-e166. PubMed ID: 29061594
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445-2448.
    Ceriello A; Prattichizzo F
    Diabetes Care; 2023 Jan; 46(1):e12. PubMed ID: 36548708
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445-2448.
    Lachin JM; Bebu I; Gao X; Nathan DM; Zinman B
    Diabetes Care; 2023 Jan; 46(1):e13. PubMed ID: 36548707
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on: Lachin et al. (2007) The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the diabetes control and complications trial: Diabetes 56:1913-1921, 2007.
    Chalew S; Hempe J; McCarter R
    Diabetes; 2008 Feb; 57(2):e4; author reply e5. PubMed ID: 18227521
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus.
    Mattila TK; de Boer A
    Drugs; 2010 Dec; 70(17):2229-45. PubMed ID: 21080740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on Lacy et al. Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes. Diabetes Care 2018;41:2339-2345.
    Medrano-De-Ávila C; Castillo-Castro C; Lavalle-González FJ
    Diabetes Care; 2019 Apr; 42(4):e68. PubMed ID: 30894390
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Comment on Lacy et al. Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes. Diabetes Care 2018;41:2339-2345.
    Lacy ME; Gilsanz P; Karter AJ; Quesenberry CP; Pletcher MJ; Whitmer RA
    Diabetes Care; 2019 Apr; 42(4):e69. PubMed ID: 30894391
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment on Hásková et al. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial. Diabetes Care 2020;43:2744-2750.
    Seibold A
    Diabetes Care; 2021 Apr; 44(4):e75-e76. PubMed ID: 33741703
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to Comment on Hásková et al. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial. Diabetes Care 2020;43:2744-2750.
    Šoupal J; Hásková A; Prázný M
    Diabetes Care; 2021 Apr; 44(4):e77-e78. PubMed ID: 33741704
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on Celis-Morales et al. Type 2 Diabetes, Glycemic Control, and Their Association With Dementia and Its Major Subtypes: Findings From the Swedish National Diabetes Register. Diabetes Care 2022;45:634-641.
    Meng X; Wang Y
    Diabetes Care; 2023 May; 46(5):e106. PubMed ID: 37185676
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on: Wolpert et al. Dietary fat acutely increases glucose concentrations and insulin requirements in patients with type 1 diabetes: implications for carbohydrate-based bolus dose calculation and intensive diabetes management. Diabetes Care 2013;36:810-816.
    Wolever TM
    Diabetes Care; 2013 Dec; 36(12):e211. PubMed ID: 24265380
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to comment on: Wolpert et al. Dietary fat acutely increases glucose concentrations and insulin requirements in patients with type 1 diabetes: implications for carbohydrate-based bolus dose calculation and intensive diabetes management. Diabetes Care 2013;36:810-816.
    Wolpert HA
    Diabetes Care; 2013 Dec; 36(12):e212. PubMed ID: 24265381
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment on "The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System" by Bailey et al.
    Freckmann G; Pleus S; Schlüter S; Heinemann L
    Diabetes Technol Ther; 2016 May; 18(5):334-5. PubMed ID: 26900898
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to Comment on Liu et al. Incidence of Type 1 Diabetes May Be Underestimated in the Chinese Population: Evidence From 21.7 Million People Between 2007 and 2017. Diabetes Care 2021;44:2503-2509.
    Liu C; Yang JK
    Diabetes Care; 2022 Jan; 45(1):e13-e14. PubMed ID: 34986252
    [No Abstract]   [Full Text] [Related]  

  • 18. Comment on "The effect of timing of remotely supervised exercise on glucose control in people with type 1 diabetes during Ramadan: A randomised crossover study" by Ozairi E et al.
    Asim A; Kumar S; Khatri M
    Diabetes Metab Syndr; 2024 Feb; 18(2):102967. PubMed ID: 38412695
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to the Comment on "The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System" by Bailey et al.
    Bailey TS; Alva S; Bode BW; Christiansen MP; Klaff LJ
    Diabetes Technol Ther; 2016 May; 18(5):336-7. PubMed ID: 27096931
    [No Abstract]   [Full Text] [Related]  

  • 20.
    Amiel SA
    Diabetes Technol Ther; 2023 May; 25(5):299-301. PubMed ID: 37017473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.